Abbott Historical Cash Flow

ABBOTINDIA   27,723  345.10  1.26%   
Analysis of Abbott India cash flow over time is an excellent tool to project Abbott India Limited future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 546.7 M or Free Cash Flow of 12.2 B as it is a great indicator of Abbott India ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Abbott India Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Abbott India Limited is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott India Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Abbott Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Abbott balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Abbott's non-liquid assets can be easily converted into cash.

Abbott India Cash Flow Chart

At this time, Abbott India's Dividends Paid is very stable compared to the past year. As of the 1st of December 2024, Capital Expenditures is likely to grow to about 507.5 M, though Other Cashflows From Financing Activities is likely to grow to (514 M).

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Abbott India Limited to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Abbott India operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Abbott India's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Abbott India Limited current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott India Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, Abbott India's Dividends Paid is very stable compared to the past year. As of the 1st of December 2024, Capital Expenditures is likely to grow to about 507.5 M, though Other Cashflows From Financing Activities is likely to grow to (514 M).
 2021 2023 2024 (projected)
Capital Expenditures440.7M483.3M507.5M
Dividends Paid5.8B6.9B7.3B

Abbott India cash flow statement Correlations

0.050.380.440.10.37-0.570.310.330.170.15-0.51-0.340.36-0.23-0.240.35-0.06
0.050.280.49-0.280.19-0.190.040.20.59-0.04-0.130.470.080.090.470.090.13
0.380.280.720.720.94-0.580.850.950.83-0.2-0.63-0.050.57-0.090.40.910.09
0.440.490.720.230.54-0.380.470.570.61-0.01-0.770.060.33-0.190.60.540.09
0.1-0.280.720.230.74-0.290.850.720.56-0.38-0.33-0.30.380.00.170.720.16
0.370.190.940.540.74-0.610.80.930.76-0.27-0.5-0.020.74-0.020.20.9-0.04
-0.57-0.19-0.58-0.38-0.29-0.61-0.61-0.66-0.450.140.170.29-0.33-0.04-0.19-0.660.49
0.310.040.850.470.850.8-0.610.820.73-0.33-0.35-0.20.350.130.30.80.09
0.330.20.950.570.720.93-0.660.820.79-0.28-0.54-0.220.47-0.220.370.94-0.06
0.170.590.830.610.560.76-0.450.730.79-0.29-0.40.060.35-0.010.550.680.21
0.15-0.04-0.2-0.01-0.38-0.270.14-0.33-0.28-0.290.150.240.030.26-0.18-0.180.1
-0.51-0.13-0.63-0.77-0.33-0.50.17-0.35-0.54-0.40.150.22-0.320.6-0.31-0.53-0.17
-0.340.47-0.050.06-0.3-0.020.29-0.2-0.220.060.240.220.320.64-0.02-0.170.23
0.360.080.570.330.380.74-0.330.350.470.350.03-0.320.320.24-0.220.50.0
-0.230.09-0.09-0.190.0-0.02-0.040.13-0.22-0.010.260.60.640.24-0.13-0.130.03
-0.240.470.40.60.170.2-0.190.30.370.55-0.18-0.31-0.02-0.22-0.130.340.0
0.350.090.910.540.720.9-0.660.80.940.68-0.18-0.53-0.170.5-0.130.34-0.02
-0.060.130.090.090.16-0.040.490.09-0.060.210.1-0.170.230.00.030.0-0.02
Click cells to compare fundamentals

Abbott India Account Relationship Matchups

Abbott India cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory796.2M(1.9B)297.8M389.7M292.6M307.2M
Change In Cash81.3M731.3M(855.6M)1.1B520.7M546.7M
Free Cash Flow6.1B7.0B9.0B8.6B11.6B12.2B
Change In Working Capital698.2M112.6M1.3B231.3M1.3B1.4B
Begin Period Cash Flow1.4B1.5B2.2B1.3B2.4B2.5B
Other Cashflows From Financing Activities(786.7M)(505.6M)(530.2M)(543.6M)(541.1M)(514.0M)
Depreciation596.1M581.3M661M699.7M711.7M747.3M
Other Non Cash Items(1.0B)(614.7M)(3.4B)(4.9B)(2.0B)(1.9B)
Dividends Paid1.2B1.4B5.3B5.8B6.9B7.3B
Capital Expenditures157.3M233.1M440.7M341.1M483.3M507.5M
Total Cash From Operating Activities6.3B7.3B9.5B8.9B12.1B12.7B
Net Income8.0B9.3B10.8B12.7B12.0B12.6B
Total Cash From Financing Activities(2.2B)(5.8B)(6.4B)(6.4B)(7.4B)(7.1B)
End Period Cash Flow1.5B2.2B1.3B2.4B2.9B3.1B
Investments(5.1B)(1.4B)(4.2B)(1.5B)(4.2B)(4.4B)
Total Cashflows From Investing Activities(4.0B)(718.2M)(4.0B)(1.5B)(1.3B)(1.4B)
Change To Account Receivables(419.6M)647.8M(391.7M)(287.3M)(16.8M)(17.6M)
Change To Operating Activities(170.3M)406.7M279.6M232.1M266.9M280.3M
Other Cashflows From Investing Activities1.2B864.8M689.9M(1.1B)(1.3B)(1.2B)
Change To Netincome(1.0B)(949.2M)(322.6M)(460.8M)(414.7M)(435.5M)
Change To Liabilities1.9B(85.1M)1.1B1.2B1.3B949.4M
Stock Based Compensation87.7M97.5M129.3M122.2M140.7M105.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Abbott Stock

The Cash Flow Statement is a financial statement that shows how changes in Abbott balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Abbott's non-liquid assets can be easily converted into cash.